Type | Sym | Class | Transaction | Value $ | Shares | Change % | Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | PRA | Common Stock | Award | $204K | +14K | +197.15% | $14.57 | 21.1K | May 23, 2024 | Direct | F1 |
Id | Content |
---|---|
F1 | These shares are awarded under the ProAssurance Corporation Director Deferred Stock Compensation Plan and are exempt under Rule 16b-3. This grant was recommended by the Compensation Committee, which is composed entirely of independent directors (as disclosed on page 12 of our 2024 Proxy Statement) and was approved by our Board of Directors at its meeting on May 22, 2024. This year, the recommended and approved stock compensation grant was for shares having a value not to exceed $95,000. The number of whole shares was determined using the closing price of a share of stock on the New York Stock Exchange (NYSE) on the day following the Board of Directors meeting following the Annual Meeting of Shareholders. The NYSE closing price on May 23, 2024 was $14.57, resulting in a distribution to each non-management director of 6,520 shares. The remaining 7,468 shares represent compensation for services to the Board for the preceding twelve months. |